STRS Ohio’s Korro Bio KRRO Stock Holding History

STRS Ohio’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-356	Closed	-$169K	–	2333
2021 Q1	$169K	Buy	356 +326	+1,087%	+$633K	﹤0.01%	1834
2020 Q4	$52K	Hold	30	–	–	﹤0.01%	1989
2020 Q3	$28K	Hold	30	–	–	﹤0.01%	2048
2020 Q2	$34K	Hold	30	–	–	﹤0.01%	1967
2020 Q1	$26K	Hold	30	–	–	﹤0.01%	1875
2019 Q4	$26K	Buy	+30	New	+$23.3K	﹤0.01%	1956

Other funds holding KRRO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SDIC

South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

STRS Ohio's KRRO Position: Q2 2021 in Review

STRS Ohio sold out of Korro Bio (KRRO) in Q2 2021, closing a stake of 356 shares — an estimated $169K sold.

STRS Ohio first reported a position in KRRO in Q4 2019 and held it in 6 quarters. The position peaked at $169K in Q1 2021. 91 funds tracked by Wall St. Rank hold KRRO as of Q2 2021.

STRS Ohio reported no remaining Korro Bio position as of Q2 2021 after selling out during the quarter.
STRS Ohio sold 356 Korro Bio shares in Q2 2021, an estimated $169K.
STRS Ohio first reported a position in Korro Bio in Q4 2019 and held it in 6 quarters.
STRS Ohio's Korro Bio position peaked at $169K in Q1 2021.
91 funds tracked by Wall St. Rank held Korro Bio as of Q2 2021.

Based on STRS Ohio's 13F filing for Q2 2021, filed 26 Jul 2021.